English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Between 2007 and 2010, only 52.5% of people with type 2 diabetes mellitus achieved a hemoglobin A1c level of less than 7.0%.1 This statistic is alarming. Inadequate glycemic control not only puts a patient at risk for cardiovascular disease, it also remains the leading cause of blindness, kidney failure, and nontraumatic lower-limb amputations in the United States.2 The total estimated cost of diagnosed diabetes in 2012 was $245 billion, including $176 billion in direct medical costs and $69 billion in reduced productivity.3 This cost is not sustainable. If we continue to approach diabetes management in the same manner, we will simply continue to observe the same outcomes. Without a significant change in the way we approach patients with diabetes, our country will not be able to withstand the staggering costs associated with diabetes management, especially given that the prevalence of type 2 diabetes mellitus continues to rise, now estimated to affect more than 19.1 million people in the United States, including 8.1 million who remain undiagnosed.3 Changing the way we approach patients with diabetes, as well as those with other chronic health conditions, starts with transforming the model in which we administer health care. Movement away from the traditional fee-for-service model of reimbursement has been long overdue, as this method has failed to improve health outcomes or rein in the ever-increasing cost of health care. The fee-for-service model of reimbursement led to a fragmented, inefficient, and poorly coordinated health care system. The new models of health care emphasize improving health outcomes and reducing cost through care coordination. The patient-centered medical home (PCMH) model strives to create a strong partnership between the patient and primary care physician, focusing on disease prevention and improving patient safety and the quality of care (ie, improving outcomes), all while reducing cost. In this model, the primary care physician leads the health care delivery team. The accountable care organization (ACO) model has similar goals to that of the PCMH model; however, the ACO reach is much broader, incorporating hospital systems, specialists, and home health care providers. Only time will tell if these models of health care delivery will be effective in reducing the cost of health care and improving access without compromising patient safety and quality of care.4 Although there is much uncertainty surrounding these models of health care delivery, one issue appears very clear: identifying and overcoming the barriers to achieving glycemic targets will become ever-more important, not only to prevent diabetes-related complications, but also to ensure reimbursement for the medical care associated with diabetes management as health care organizations begin to assume greater shared financial risk in the newer payment models. The role of the patient is also changing. Patients are becoming “health care Diabetes, Patient-Centered Medical Homes, and Accountable Care Organizations, Oh My!